当前位置:首页 - 行情中心 - 华仁药业(300110) - 财务分析

华仁药业

(300110)

  

流通市值:40.84亿  总市值:40.90亿
流通股本:11.80亿   总股本:11.82亿

华仁药业(300110)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.52亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益281833.36万元,未分配利润95003.99万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产500138.51万元,负债218305.15万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入406,703,155.731,636,256,356.791,215,927,751.99829,046,309.5
营业总成本340,912,234.641,404,815,482.921,032,296,689.68720,954,485.3
营业利润58,680,286.5225,944,323.3154,749,072.0488,435,618.68
利润总额57,699,011.68230,514,670.04157,214,089.0790,717,752.66
净利润52,378,184.34193,424,735.15140,650,990.5184,438,182.99
其他综合收益----
综合收益总额52,378,184.34193,424,735.15140,650,990.5184,438,182.99
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,634,864,912.752,791,426,259.672,800,949,280.782,930,145,745.6
非流动资产合计2,366,520,212.512,374,270,798.242,370,892,066.52,386,570,390.33
资产总计5,001,385,125.265,165,697,057.915,171,841,347.285,316,716,135.93
流动负债合计1,530,910,8611,516,260,018.041,743,150,283.531,952,174,280.98
非流动负债合计652,140,663.26883,481,623.21715,472,569.3707,542,630.97
负债合计2,183,051,524.262,399,741,641.252,458,622,852.832,659,716,911.95
归属于母公司股东权益合计2,744,914,6472,694,091,730.122,643,149,109.762,588,340,944.11
股东权益合计2,818,333,6012,765,955,416.662,713,218,494.452,656,999,223.98
负债和股东权益合计5,001,385,125.265,165,697,057.915,171,841,347.285,316,716,135.93
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计472,998,824.11,901,013,051.091,383,074,109.47959,756,195.17
经营活动现金流出小计362,481,991.211,595,415,577.641,186,015,299.85834,105,612.78
经营活动产生的现金流量净额110,516,832.89305,597,473.45197,058,809.62125,650,582.39
投资活动现金流入小计-10,329,952.6210,327,200.3410,327,200.34
投资活动现金流出小计12,045,611.27107,466,500.0895,580,665.1785,762,555.78
投资活动产生的现金流量净额-12,045,611.27-97,136,547.46-85,253,464.83-75,435,355.44
筹资活动现金流入小计130,000,0001,574,171,348.51,384,906,6821,093,048,000
筹资活动现金流出小计351,122,266.651,694,895,620.751,487,054,633.771,015,876,746.89
筹资活动产生的现金流量净额-221,122,266.65-120,724,272.25-102,147,951.7777,171,253.11
汇率变动对现金及现金等价物的影响-1,520.6-1,405.6-1,970.06-272.56
现金及现金等价物净增加额-122,652,565.6387,735,248.149,655,422.96127,386,207.5
期末现金及现金等价物余额109,212,748.61231,865,314.24153,785,489.06271,516,273.6
TOP↑